Josh Wolfe - Director, 10%+ Owner at Eikon Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Issuer Symbol
EIKN on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Josh Wolfe since 10 Mar 2025

Holdings reported by Josh Wolfe for Eikon Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2,294,653 06 Feb 2026 Indirect
Series A-1 Preferred Stock 0 06 Feb 2026 Indirect Common Stock
Series A Preferred Stock 0 06 Feb 2026 Indirect Common Stock
Series B-1 Preferred Stock 0 06 Feb 2026 Indirect Common Stock
Series B Preferred Stock 0 06 Feb 2026 Indirect Common Stock
Series C-1 Preferred Stock 0 06 Feb 2026 Indirect Common Stock
Series C Preferred Stock 0 06 Feb 2026 Indirect Common Stock
Series D Preferred Stock 0 06 Feb 2026 Indirect Common Stock

Transactions reported by Josh Wolfe for Eikon Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.